# ProX MS

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/prox-ms

- Industry: Medical Devices & Equipment
- Headquarters: Ningbo, China
- Website: http://www.proxms.com/
- Latest round: Series A (Feb 14, 2026)
- Investors on record: 3

## About

Based in Ningbo, China and founded in 2020, Ningbo Puxiu Technology Co., Ltd., trading as ProX MS, specializes in the development and production of UPLC (ultra-high pressure liquid chromatography) and tandem mass spectrometry systems. It has launched several clinical mass spectrometry devices, including the NGM, C45, C65, and SCT models.
In February 2026, Prox MS raised a series A funding from new investors Bison Capital, Ningbo Science and Technology Financial Service Center, MF Capital.
The series A round of financing will be used to strengthen technology research and development, expand production lines, and apply for registration, so as to promote the large-scale application of domestically produced high-end clinical mass spectrometry equipment in hospitals and third-party laboratories.

## Funding rounds

- Series A, Feb 14, 2026 — Ningbo Science and Technology Financial Service Center, Bison Capital, MF Capital

## Investors

- Ningbo Science and Technology Financial Service Center — Series A
- Bison Capital — Series A
- MF Capital (https://capitalatlas.ai/funds/mf-capital) — Series A